Year: 2017
Type: erratum
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd.2017.257
Institution: AstraZeneca (United Kingdom)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: drug discovery, enzyme inhibitors
Open Access status: bronze
OpenAlex ID: W2775548182
